Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barbaud

Showing results (311-320 of 332) with videos related to

Pageof 34
Sort By:
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Contribution of an emergency dermatology consultation in a French cancer centre]M Reigneau, F Granel-Brocard, L Geoffrois, et al.
Current Pharmaceutical Design|November 11, 2008
Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivityJ L Guéant, R M Guéant-Rodriguez, I Aimone Gastin, et al.
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)A Barbaud, J Waton, B Herbeth, et al.
Allergy|July 30, 2013
Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphismsA C Bursztejn, A Romano, R M Guéant-Rodriguez, et al.
Clinical and Translational Allergy|March 16, 2017
Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North AmericaM J Torres, A Romano, G Celik, et al.
The British Journal of Dermatology|November 10, 2012
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactionsA Barbaud, E Collet, B Milpied, et al.
Annales De Dermatologie Et De Venereologie|November 16, 2010
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)]V Descamps, B Ben Saïd, B Sassolas, et al.
Allergy|December 12, 2023
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paperC Mayorga, G E Çelik, M Pascal, et al.
Allergy|January 31, 2009
Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter studyK Brockow, A Romano, W Aberer, et al.
Pageof 34

Showing results (311-320 of 332) with videos related to

Sort By:
Pageof 34
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Contribution of an emergency dermatology consultation in a French cancer centre]M Reigneau, F Granel-Brocard, L Geoffrois, et al.
Current Pharmaceutical Design|November 11, 2008
Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivityJ L Guéant, R M Guéant-Rodriguez, I Aimone Gastin, et al.
The British Journal of Dermatology|June 22, 2018
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE studyF Bérard, M C Ferrier Le Bouedec, L Bouillet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS)A Barbaud, J Waton, B Herbeth, et al.
Allergy|July 30, 2013
Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphismsA C Bursztejn, A Romano, R M Guéant-Rodriguez, et al.
Clinical and Translational Allergy|March 16, 2017
Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North AmericaM J Torres, A Romano, G Celik, et al.
The British Journal of Dermatology|November 10, 2012
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactionsA Barbaud, E Collet, B Milpied, et al.
Annales De Dermatologie Et De Venereologie|November 16, 2010
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)]V Descamps, B Ben Saïd, B Sassolas, et al.
Allergy|December 12, 2023
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paperC Mayorga, G E Çelik, M Pascal, et al.
Allergy|January 31, 2009
Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter studyK Brockow, A Romano, W Aberer, et al.
Pageof 34